|
1
|
Januškevičienė I and Petrikaitė V:
Heterogeneity of breast cancer: The importance of interaction
between different tumor cell populations. Life Sci. 239:1170092019.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wörmann B: Breast cancer: Basics,
screening, diagnostics and treatment. Med Monatsschr Pharm.
40:55–64. 2017.PubMed/NCBI
|
|
3
|
Zeng Y, Zhang J, Meng J, Numthuam S and
Naruse K: Application of multi-modal imaging mediated by iron
carbon nanoparticles based on reinforcement learning in the
diagnosis of breast nodules. J Nanosci Nanotechnol. 21:1154–1160.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Anastasiadi Z, Lianos GD, Ignatiadou E,
Harissis HV and Mitsis M: Breast cancer in young women: An
overview. Updates Surg. 69:313–317. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang Z and Teng CT: Estrogen receptor
alpha and estrogen receptor-related receptor alpha1 compete for
binding and coactivator. Mol Cell Endocrinol. 172:223–233. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sauvé F, McBroom LD, Gallant J, Moraitis
AN, Labrie F and Giguère V: CIA, a novel estrogen receptor
coactivator with a bifunctional nuclear receptor interacting
determinant. Mol Cell Biol. 21:343–353. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jiang C, Ito M, Piening V, Bruck K, Roeder
RG and Xiao H: TIP30 interacts with an estrogen receptor
alpha-interacting coactivator CIA and regulates c-myc
transcription. J Biol Chem. 279:27781–27789. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu CY and Feng GS: NCOA5, a molecular
link between type 2 diabetes and liver cancer. Hepatobiliary Surg
Nutr. 3:106–108. 2014.PubMed/NCBI
|
|
9
|
Liu X, Liu F, Gao S, Reske J, Li A, Wu CL,
Yang C, Chen F, Luo R and Xiao H: A single non-synonymous NCOA5
variation in type 2 diabetic patients with hepatocellular carcinoma
impairs the function of NCOA5 in cell cycle regulation. Cancer
Lett. 391:152–161. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dhar D, Seki E and Karin M: NCOA5, IL-6,
type 2 diabetes, and HCC: The deadly quartet. Cell Metab. 19:6–7.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Facciorusso A and Barone M: Glucose
intolerance and hepatocellular carcinoma: Recent findings for old
diseases. Hepatobiliary Surg Nutr. 3:91–92. 2014.PubMed/NCBI
|
|
12
|
He J, Zhang W, Li A, Chen F and Luo R:
Knockout of NCOA5 impairs proliferation and migration of
hepatocellular carcinoma cells by suppressing
epithelial-to-mesenchymal transition. Biochem Biophys Res Commun.
500:177–183. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sun K, Wang S, He J, Xie Y, He Y, Wang Z
and Qin L: NCOA5 promotes proliferation, migration and invasion of
colorectal cancer cells via activation of PI3K/AKT pathway.
Oncotarget. 8:107932–107946. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zheng ZC, Wang QX, Zhang W, Zhang XH and
Huang DP: A novel tumor suppressor gene NCOA5 is correlated with
progression in papillary thyroid carcinoma. OncoTargets Ther.
11:307–311. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ye XH, Huang DP and Luo RC: NCOA5 is
correlated with progression and prognosis in luminal breast cancer.
Biochem Biophys Res Commun. 482:253–256. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ranhotra HS: Estrogen-related receptor
alpha and cancer: Axis of evil. J Recept Signal Transduct Res.
35:505–508. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gao S, Li A, Liu F, Chen F, Williams M,
Zhang C, Kelley Z, Wu CL, Luo R and Xiao H: NCOA5
haploinsufficiency results in glucose intolerance and subsequent
hepatocellular carcinoma. Cancer Cell. 24:725–737. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liang Y, Zhang T, Shi M, Zhang S, Guo Y,
Gao J and Yang X: Low expression of NCOA5 predicts poor prognosis
in human cervical cancer and promotes proliferation, migration, and
invasion of cervical cancer cell lines by regulating notch3
signaling pathway. J Cell Biochem. 120:6237–6249. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen GQ, Tian H, Yue WM, Li L, Li SH, Qi
L, Gao C, Si LB and Lu M: NCOA5 low expression correlates with
survival in esophageal squamous cell carcinoma. Med Oncol.
31:3762014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu Y, Wu J, Dong QR and Guo NZ:
Association between expression of nuclear receptor co-activator 5
protein and prognosis in postoperative patients with osteosarcoma.
Oncol Lett. 15:1888–1892. 2018.PubMed/NCBI
|
|
22
|
Yuan X, Zhang L, Cui Y, Yu Y, Gao X and Ao
J: NCOA5 is a master regulator of amino acid-induced mTOR
activation and β-casein synthesis in bovine mammary epithelial
cells. Biochem Biophys Res Commun. 529:569–574. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li Y, Zhang T, Qin S, Wang R, Li Y, Zhou
Z, Chen Y, Wu Q and Su F: Effects of UPF1 expression on EMT process
by targeting E cadherin, N cadherin, Vimentin and Twist in a
hepatocellular carcinoma cell line. Mol Med Rep. 19:2137–2143.
2019.PubMed/NCBI
|
|
24
|
Yamashita N, Tokunaga E, Iimori M, Inoue
Y, Tanaka K, Kitao H, Saeki H, Oki E and Maehara Y: Epithelial
Paradox: Clinical significance of coexpression of e-cadherin and
vimentin with regard to invasion and metastasis of breast cancer.
Clin Breast Cancer. 18:e1003–e1009. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Paolillo M and Schinelli S: Extracellular
matrix alterations in metastatic processes. Int J Mol Sci.
20:202019. View Article : Google Scholar
|
|
26
|
Diepenbruck M and Christofori G:
Epithelial-mesenchymal transition (EMT) and metastasis: Yes, no,
maybe? Curr Opin Cell Biol. 43:7–13. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chaffer CL, San Juan BP, Lim E and
Weinberg RA: EMT, cell plasticity and metastasis. Cancer Metastasis
Rev. 35:645–654. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bill R and Christofori G: The relevance of
EMT in breast cancer metastasis: Correlation or causality? FEBS
Lett. 589:1577–1587. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wong SHM, Fang CM, Chuah LH, Leong CO and
Ngai SC: E-cadherin: Its dysregulation in carcinogenesis and
clinical implications. Crit Rev Oncol Hematol. 121:11–22. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang X, Liu G, Kang Y, Dong Z, Qian Q and
Ma X: N-cadherin expression is associated with acquisition of EMT
phenotype and with enhanced invasion in erlotinib-resistant lung
cancer cell lines. PLoS One. 8:e576922013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Guo L, Zhang K and Bing Z: Application of
a co expression network for the analysis of aggressive and non
aggressive breast cancer cell lines to predict the clinical outcome
of patients. Mol Med Rep. 16:7967–7978. 2017. View Article : Google Scholar : PubMed/NCBI
|
